MDGL icon

Madrigal Pharmaceuticals
MDGL

Overview Fund Activity

53 hedge funds and large institutions have $120M invested in Madrigal Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.

Holders
53
Holders Change
+11
Holders Change %
+26.19%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
15
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$24.9M
2
FCMI
2
Foresite Capital Management III
California
$4.5M
3
AC
3
Ascend Capital
California
$3.31M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$6.45M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$5.73M

Top Sellers

1
RSCM
1
Rock Springs Capital Management
Maryland
$12.4M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$22.5M
3
AC
3
Armistice Capital
New York
$9.54M
4
Citigroup
4
Citigroup
New York
$0
5
DADC
5
D.A. Davidson & Co
Montana
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
51
Meeder Asset Management
Ohio
$1K +$1K +17 New
TC
52
TFS Capital
Pennsylvania
– -$207K -12,703 Closed
Citigroup
53
Citigroup
New York
– -$185K -11,351 Closed
DADC
54
D.A. Davidson & Co
Montana
– -$64K -3,950 Closed
Creative Planning
55
Creative Planning
Kansas
– -$3K -170 Closed
NA
56
NewEdge Advisors
Louisiana
– -$901 -57 Closed
GEA
57
Glen Eagle Advisors
New Jersey
– -$228 -14 Closed
1 2
3